A professional organization representing healthcare providers who treat HIV/AIDS is acknowledging the prevalence of hepatitis C infection through the creation of an institute focusing on the illness.
The board of directors for the American Academy of HIV Medicine voted to establish the AAHIVM Institute for Hepatitis C, which will seek to advance hepatitis C care through education, professional development and advocacy. According to a Nov. 11 news release, the academy recently conducted a survey that reported that around one in four patients being seen by HIV treatment providers in community clinics, private practices and other settings is infected with hepatitis C.
While 81% of the clinicians who responded to the survey said they believed they had the proper knowledge to treat hepatitis C effectively, 92% also said they would like even more professional support on this subject. “It is clear that HIV providers are more engaged in [hepatitis C] care than ever before,” said academy executive director James M. Friedman.
Offerings of the new institute will include a monthly practice-focused e-newsletter that will share both clinical and non-clinical information to guide the treatment of hepatitis C.